Iuliia Efimova
Impact in
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
-
- Ferroptosis and cancer prognosis
- Photodynamic Therapy Research Studies
Papers in
-
- Ferroptosis and cancer prognosis 4
- Photodynamic Therapy Research Studies 3
-
- Immunotherapy and Immune Responses 3
- Immune cells in cancer 3
- Phagocytosis and Immune Regulation 2
- Co-authors
- Dmitri V. Krysko (12 shared papers)Olga Krysko (6 shared papers)Victoria D. Turubanova (4 shared papers)Elena Catanzaro (5 shared papers)Claus Bachert (4 shared papers)Tatiana A. Mishchenko (5 shared papers)Maria V. Vedunova (5 shared papers)Frauke Coppieters (2 shared papers)
In The Last Decade
Iuliia Efimova
12 papers receiving 830 citations
Iuliia Efimova's Hit Papers
Peers
Comparison fields: 5 of 65
- Cancer Research 267
- Pulmonary and Respiratory Medicine 527
- Immunology 233
- Oncology 240
- Biomedical Engineering 243
Countries citing papers authored by Iuliia Efimova
This map shows the geographic impact of Iuliia Efimova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iuliia Efimova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iuliia Efimova more than expected).
Fields of papers citing papers by Iuliia Efimova
This network shows the impact of papers produced by Iuliia Efimova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iuliia Efimova. The network helps show where Iuliia Efimova may publish in the future.
Co-authors
The 25 scholars most cited alongside Iuliia Efimova, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity Hit paper breakdown → | 2020 | 367 |
| 2 | 2019 | 220 | |
| 3 | 2021 | 100 | |
| 4 | 2021 | 47 | |
| 5 | 2022 | 30 | |
| 6 | 2020 | 25 | |
| 7 | 2022 | 15 | |
| 8 | 2023 | 12 | |
| 9 | 2023 | 7 | |
| 10 | 2024 | 6 | |
| 11 | 2023 | 3 | |
| 12 | 2024 | 2 |
About Iuliia Efimova
Iuliia Efimova is a scholar working on Pulmonary and Respiratory Medicine, Immunology, Oncology, Molecular Biology and Biomedical Engineering, having authored 12 papers that have together received 834 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (4 papers), Nanoplatforms for cancer theranostics (3 papers), Photodynamic Therapy Research Studies (3 papers), Immunotherapy and Immune Responses (3 papers), Immune cells in cancer (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Phagocytosis and Immune Regulation (2 papers) and Extracellular vesicles in disease (2 papers). The work is most often cited by research in Cancer Research (267 citations), Pulmonary and Respiratory Medicine (527 citations), Immunology (233 citations), Oncology (240 citations) and Biomedical Engineering (243 citations). Iuliia Efimova has collaborated with scholars based in Belgium, Russia and Italy. Frequent co-authors include Dmitri V. Krysko, Olga Krysko, Victoria D. Turubanova, Elena Catanzaro, Claus Bachert, Tatiana A. Mishchenko, Maria V. Vedunova, Frauke Coppieters, Louis Van der Meeren and André G. Skirtach. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Cells, Scientific Reports, Cell Death and Disease and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.